Condition: Chronic Kidney Diseases · Anemia of Chronic Kidney Disease · Sponsor: Zydus Lifesciences Limited
A Phase 4, 52 week, single arm, multicentre post marketing surveillance to evaluate the safety of Desidustat for the treatment of anemia in subjects with chronic kidney disease (CKD)
This description comes directly from the study's public registry record.
Dr Kevin Kansagra, MD · 02717-665555 · kevinkumarkansagra@zyduslife.com
Always discuss trial participation with your own doctor first.
| Indira Gandhi Institute of Medical Sciences | Sheikhpura, Bihar, India | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05515367